Xiamen Humanity Hospital
| 中国 | トルコ | オーストリア | |
| 透析 | から $200 | から $200 | から $400 |
| 血漿交換術 | から $2,200 | から $1,200 | から $2,000 |
| 腎盂形成術 | から $11,000 | から $4,500 | から $14,000 |
| 腎摘出術 | から $14,500 | から $10,000 | から $22,000 |
| 尿道鏡的結石破砕術 | から $4,800 | から $1,500 | から $3,200 |
Bookimedは腎臓内科治療価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。国に到着時にクリニックで治療代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。腎臓内科治療で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。腎臓内科治療の旅路でお一人になることはありません。
Dr. Zhang Yan Lin is a nationally recognized nephrologist with over 30 years in clinical care, teaching, and research. Dr. Zhang previously worked at the First Affiliated Hospital of Xiamen University.
Dr. Zhang took part in two NSFC projects, served as principal investigator for one Fujian Provincial NSFC project, and led two Xiamen Municipal key projects. Dr. Zhang is chief editor of one monograph and co-editor of three. Dr. Zhang has published more than 30 papers, including six in SCI journals.
Appointments: Deputy Chair of the Immunoadsorption and Cell Therapy Group of the Internal Medicine Branch of the Chinese Medical Association. Deputy Chair of the Nephrology Branch of the Asia-Pacific Academy of Medical and Biological Immunology. Standing Committee Member of the Nephrology and Dialysis Professional Committee of the China Non-Public Medical Institutions Association. Standing Committee Member of the East China Regional Nephrology Cooperation Committee.
Professor Fan Yu is Chief Physician and Director of Kidney Transplantation. His center ranked first in Fujian for three straight years in liver and kidney transplants. His team performed 112 kidney transplants and one combined liver-kidney transplant over two years.
He specializes in kidney transplantation, post-transplant complications, and immunosuppressive management. He developed a system to improve long-term graft and patient survival.
He pioneered the diagnosis and treatment of chronic and subclinical rejection. He has led more than 10 grants as principal investigator and published over 30 SCI-indexed papers. He is Vice Chairman of the Transplant Surgeon Branch of the Chinese Medical Doctor Association and the Organ Transplant Branch of the Shanghai Medical Association. He is Editor-in-Chief of Chinese Kidney Friends and serves on the editorial boards of over 20 journals, including the Chinese edition of Transplantation.
The best hospitals for kidney disease in China are concentrated in Beijing, Shanghai, Guangzhou, and Nanjing. Peking University First Hospital and Chinese PLA General Hospital are top-tier facilities for nephrology. These centers specialize in advanced dialysis, renal replacement therapies, and complex kidney transplant procedures.
Bookimed Expert Insight: Data shows that Class A Level III clinics like Yanda International Hospital and Xiamen Humanity Hospital serve over 1,000,000 patients annually. These high-volume centers often house specialized departments for immunoadsorption and cell therapy. Choosing a facility with both academic research and high surgical volumes translates to better outcomes for chronic renal failure.
Patient Consensus: Patients note it is important to target triple-A hospitals in Beijing or Shanghai for the most serious cases. Many suggest bringing translated medical records to help doctors avoid errors during the initial consultation.
Primary challenges for dialysis patients in China include significant regional service gaps and financial burdens. High out-of-pocket costs and reimbursement limits often restrict treatment frequency. Patients in rural areas face infrastructure barriers. Access for non-residents is limited without a local ID or specific insurance.
Bookimed Expert Insight: High-volume centers like Yanda International Hospital serve 2.5 million patients annually. These facilities often combine international protocols with traditional Chinese approaches. Patients should prioritize JCI-accredited centers in Beijing or Guangzhou to ensure consistent hygiene standards. These top-tier hospitals typically offer more stable session slots than smaller regional clinics.
Patient Consensus: Patients note that securing a hospital spot early through social media groups is essential. Many worry about the long travel times from rural areas to reach urban centers for reliable care.
The average waiting period for a kidney transplant in China is approximately 3 to 4 years for domestic patients. Wait times vary significantly between hospitals and specific medical needs. International patients generally cannot join national waiting lists and must typically rely on a living relative donor.
Bookimed Expert Insight: While large centers like Yanda International Hospital serve 2,500,000 patients annually, they primarily focus on complex rehabilitation rather than transplant logistics. Patients seeking renal care should note that Class A Level III clinics offer the highest standards for long-term dialysis while navigating the transplant process.
Patient Consensus: Local residents note that waiting times on dialysis can vary based on financial resources and hospital location. Many emphasize the importance of verifying donor information independently and planning for long-term post-operative monitoring after returning home.
China reports kidney transplant survival rates comparable to international benchmarks. The 1-year recipient survival for deceased donor transplants is approximately 97.8%. Living-related donor cases reach nearly 99.4% survival. These figures meet or exceed averages found in the United States and Europe.
Bookimed Expert Insight: High-volume centers like Yanda International Hospital and Xiamen Humanity Hospital manage over 1,000,000 patients annually each. This massive surgical volume often leads to highly refined perioperative protocols. Large-scale clinical trial capacity at Xiamen Humanity Hospital further suggests a strong integration of new pharmacological standards.
Patient Consensus: While short-term outcomes at top hospitals match international standards, patients emphasize the need for strict long-term follow-up care. Some note that maintaining stable health requires consistent access to regulated immunosuppressant medications after returning home.